Using a bleomycin (BLM)-induced SSc mouse model, researchers assessed whether LMWH treatment could improve ASC functionality, specifically their migration ability and hepatocyte growth factor (HGF) secretion. This evidence concerns the gene HGF and systemic sclerosis.